ANDA 85094, held by Watson Labs. Triprolidine Hydrochloride.
As of Nov 15, 2026, ANDA 85094 (Triprolidine Hydrochloride), held by Watson Labs, was first approved by FDA on Feb 7, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 7, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Triprolidine Hydrochloride2.5MG ยท tablet;oral | Triprolidine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
